USX:ELDN - Eledon Pharmaceuticals Inc Eledon Pharmaceuticals Inc
Sector: Health Care, Industry: Biotechnology
Next Earnings: 9 May 2024
Add to Watchlist
   
Add Alert 


Yahoo Finance

USD 2.06    -0.07 (-3.29%)

28 Mar 2024


Loading...
Loading...
Loading...

General

CEO: Dr. David-Alexandre C. Gros M.D., Ph.D.

IPO: 2014-09-17

Headquarters: US

Employees: 17

Homepage

Description

Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and for patients living with ALS. The company's lead compound in development is AT-1501 which is the next generation anti-CD40L antibody.

Your Holdings
Dashboard
Portfolio
Options

Tools
Screener
Watchlist
Alerts
Notes
Community
Forum
Blog
YouTube
Shared Portfolios
Shared Screeners

Collab with Brokerages
Moomoo x StocksCafe
Tiger x StocksCafe

Help
Quickstart Guides
StocksCafe Academy
StocksCafe Youtube Channel

About StocksCafe
Our Story
Send Feedback
Pricing
Market
Singapore
Hong Kong
Tokyo
Kuala Lumpur
United States
London
Shenzhen
Shanghai
Bombay
National (India)
Indexes
Singapore Savings Bonds
Singapore T-Bills
CoinGecko
Your Account
Settings
Subscriptions
Referrals
Messages
Profile
YouTube
Server T1

About · FAQs · StocksCafe © 2024 · Privacy · Terms